MiR-135a can influence cell proliferation, migration, invasion, apoptosis and tumour angiogenesis through the IGF-1/PI3K/AKT signalling pathway in non-small cell lung cancer (NSCLC) [16]. Here, IGF1 is linked to non-small cell lung carcinoma.